Duration of antimicrobial therapy for nosocomial pneumonia: possible strategies for minimizing antimicrobial use in intensive care units

被引:8
|
作者
Dugan, HA [1 ]
MacLaren, R [1 ]
Jung, R [1 ]
机构
[1] Univ Colorado, Hlth Sci Ctr, Sch Pharm, Dept Pharm Practice, Denver, CO 80262 USA
关键词
duration of antibiotic therapy; nosocomial pneumonia; shorter course;
D O I
10.1046/j.1365-2710.2003.00471.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To review published data evaluating shorter courses of antibiotic therapy for nosocomial pneumonia and provide recommendations for minimizing antimicrobial use in intensive care units. Data source: Literature was identified through MEDLINE (1966 through 6/2002) and a manual search of critical care, infectious disease, and pharmacy journals was conducted to identify relevant abstracts. Data synthesis: Antibiotic use may be decreased by discontinuing therapy after 3 days in patients with low likelihood of nosocomial pneumonia. In addition, clinical guidelines or invasive diagnostic procedures may be effectively instituted to reduce duration of antibiotic therapy. Conclusion: Shorter-course antibiotic therapy may be beneficial in decreasing lengths of hospital and intensive care units stays, antimicrobial resistance, and total hospital costs. Further research is needed to determine the optimal duration of therapy in patients with nosocomial pneumonia.
引用
收藏
页码:123 / 129
页数:7
相关论文
共 50 条
  • [31] Comparison of antimicrobial cycling and mixing strategies in two medical intensive care units
    Martínez, JA
    Nicolás, JM
    Marco, F
    Horcajada, JP
    Garcia-Segarra, G
    Trilla, A
    Codina, C
    Torres, A
    Mensa, J
    CRITICAL CARE MEDICINE, 2006, 34 (02) : 329 - 336
  • [32] Nosocomial pneumonia and mortality among patients in intensive care units
    Fagon, JY
    Chastre, J
    Vuagnat, A
    Trouillet, JL
    Novara, A
    Gibert, C
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (11): : 866 - 869
  • [33] Diagnosis and treatment of nosocomial pneumonia in patients in intensive care units
    Chastre, J
    Fagon, JY
    Trouillet, JL
    CLINICAL INFECTIOUS DISEASES, 1995, 21 : S226 - S237
  • [34] SYSTEMIC ANTIMICROBIAL THERAPY OF NOSOCOMIAL PNEUMONIA - MONOTHERAPY VERSUS COMBINATION THERAPY
    LAFORCE, FM
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1989, 8 (01) : 61 - 68
  • [36] Escherichia coli in German Intensive Care Units (2001-2007):: Data from the project Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units (SARI)
    Meyer, E.
    Gastmeier, P.
    Schroeren-Boersch, B.
    Schwab, F.
    INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2008, 298 : 56 - 56
  • [37] Antimicrobial use and antimicrobial resistance in an intensive care burn department
    K Bousselmi
    L Thabet
    A Bayoudh
    M Memi
    A Messaadi
    Critical Care, 10 (Suppl 1):
  • [38] Pathogenicity factors and antimicrobial resistance of Staphylococcus epidermidis associated with nosocomial infections occurring in intensive care units
    Michelim, L
    Lahude, M
    Araújo, PR
    Giovanaz, DSH
    Müller, G
    Delamare, APL
    da Costa, SOP
    Echeverrigaray, S
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2005, 36 (01) : 17 - 23
  • [39] TRENDS IN ANTIMICROBIAL USE IN ADULT INTENSIVE CARE UNITS BETWEEN 2009 AND 2013
    Swami, Sunil
    Regelman, Hsiaoting
    Hassan, Erkan
    Lilly, Craig
    Badawi, Omar
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [40] Point-prevalence survey of antimicrobial use in intensive care units in Nepal
    Koirala, Sabin
    Dahal, Agnimshwor
    Paneru, Hem Raj
    Thapa, Astha
    Bhusal, Surendra
    Shakya, Roshni
    Luitel, Subekshya
    Koirala, Kanchan
    Aryal, Diptesh
    ANTIMICROBIAL STEWARDSHIP & HEALTHCARE EPIDEMIOLOGY, 2024, 4 (01):